Liberal Party in turmoil over imminent plan to save Craig Kelly through emergency powers, page-76

...and the producers of HCQ ALSO say don't use it for COVID

Important Information on Plaquenil® (hydroxychloroquine)
and COVID-19

Australia, 4 June 2020 – Australia, 4 June 2020 – There has been increased media coverage around the off-label use of hydroxychloroquine in the management of COVID-19. The situation is raising some questions from our different stakeholders.


Patient safety is the priority
To date there is insufficient clinical evidence to draw definite conclusions over the clinical efficacy or safety of hydroxychloroquine in the management of COVID-19.

Today in Australia, Plaquenil® (hydroxychloroquine) is registered in rheumatoid arthritis, mild systemic and discoid lupus erythematosus and the suppression and treatment of malaria..


https://www.sanofi.com.au/en/our-products/Plaquenil-Update-Australia